Latest European Pharmaceutical Market News

Page 1 of 1

Argent BioPharma Advances with Cost Cuts, Positive CimetrA® Data, and EU Drug Approvals

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

Ada Torres

30 Apr 2025

Top